The elevation of cancer stem cells (CSCs)-like properties is involved in the initiation and progression of various human cancers. Current standard practices for treatment of cancers are less than satisfactory because of CSCs-mediated recurrence. For this reason, targeting the CSCs or the cancer cells with CSCs-like properties has become the new approach for the cancer treatments. In addition to treating leukemia, arsenic trioxide (As 2 O 3 ) also suppresses other solid tumors. However, the roles of As 2 O 3 in the regulation of CSCs-like properties remain largely uninvestigated. Here by using sphere formation assay, luciferase reporter assay, and some other molecular biology approaches, we found that As 2 O 3 attenuated the CSCs-like properties in human hepatocellular carcinoma (HCC). Briefly, in HCC cells and mice xenograft models, As 2 O 3 improved the expression of miR-491 by DNA-demethylation. MiR-491, which targeted the SMAD3-3 0 -UTR, decreased the expressions of SMAD3, and inhibited the CSCs-like properties in HCC cells. Knockdown of either miR-491 or SMAD3 attenuated the As 2 O 3 -induced inhibition of endogenous transforming growth factor beta signal and the CSCs-like properties. Further, in HCC patients, miR-491 is inversely correlated with the expressions of SMAD3, CD133, and the metastasis/recurrence outcome. By understanding a novel mechanism whereby As 2 O 3 inhibits the CSCs-like properties in HCC, our study would help in the design of future strategies of developing As 2 O 3 as a potential HCC chemopreventive agent when used alone or in combination with other current drugs.
. So the continued searches for novel agents, which exhibit relative lower cytotoxic and have repressive effects on CSCs or the cancer cells with CSCs-like properties are urgently needed.
Arsenic trioxide (As 2 O 3 ) has been used as an antitumor agent to treat the acute promyelocytic leukemia in China (Kogan, 2010) . In addition, As 2 O 3 has also been used in other solid tumors, such as liver, breast, gastric, and prostate (Chow et al., 2004; Fei et al., 2009) . In most cases, inhibition of proliferation and/or induction of apoptosis by As 2 O 3 in cancer cells is well characterized (Chow et al., 2004; Fei et al., 2009) . Moreover, As 2 O 3 also attenuates the migration/invasion potential in hepatocellular carcinoma (HCC) cells . Further, as a model agent, As 2 O 3 causes significant vascular shutdown in brain, liver, breast, and gastric cancers (Alhasan et al., 2012; Jiang et al., 2014b) . Recent studies reveal a novel function of As 2 O 3 that it depletes the CSCs population or induces the CSCs differentiation in pancreatic cancer, gliomas, glioblastoma, as well as HCC Wu et al., 2013; Zhang et al., 2014; Zhen et al., 2010) . However, the molecular mechanisms involved in remain unclear.
It has been acknowledged that the transforming growth factor beta (TGFb) signal is involved in the regulation of cell growth, differentiation, and development (Matise et al., 2012) . In human cancers, TGFb has conflicting effects during tumor progression, initially as a suppressor and then as a promoter, which drives the epithelial to mesenchymal transition (EMT) and elevates the CSCs-like properties, resulting in the enhanced metastatic ability and chemotherapy/radiation resistance Micalizzi et al., 2009) . We previously show that TGFb/SMADs signal is involved in the maintenance of CSCs-like properties in HCC cells (Jiang et al., 2014a) . Here, we hypothesize that the inhibition of TGFb signal pathway is involved in the As 2 O 3 -induced attenuation of CSCs-like properties in HCC. So, the goal of the present study is to verify this hypothesis in cell lines, mice xenograft models, and HCC tissues, with emphases on the As 2 O 3 -induced molecular changes, CSCs-like properties, and endogenous TGFb signal transduction.
MATERIALS AND METHODS
Ethics statement and patients. This study was reviewed and approved by Medical Ethics Committee of the Second Affiliated Hospital of Nanjing Medical University (Permit No. 2009-KY-002) . A cohort of 60 Chinese HCC patients was enrolled in this study. These patients underwent curative liver resection for primary tumors between October 2009 and March 2012 at The Second Affiliated Hospital of Nanjing Medical University. The inclusion and exclusion criteria were described in our previous study . All the patients had no extrahepatic metastasis when they underwent hepatectomy, and the clinicopathologic characteristics were shown in Supplementary  Table 1 .
Cell culture and reagents. MHCC97H and MHCC97L cells are HCC cell lines with high and low migratory potential, respectively, and these two cell lines were successfully established through in vivo selection of MHCC97 by Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China (Li et al., 2001) . Cells were maintained in 5% CO 2 at 37 C in Dulbecco's Modified Eagle Medium (DMEM, Life Technologies/ Gibco, Grand Island, New York) supplemented with 10% fetal bovine serum (FBS, Gibco), 100 U/ml penicillin, and 100 lg/ml streptomycin (Gibco). A mycoplasma stain assay Kit (Beyotime, Haimeng, China) was used for mycoplasma testing to rule out the possibility of cryptic contamination. Arsenic trioxide (As 2 O 3 , 99.0% purity) was purchased from Sigma Chemical Co. (St. Louis, Missouri). All the other reagents used were of analytical grade or the highest grade available.
Animals. This study was performed according to a protocol approved by the Nanjing Medical University Institutional Animal Care and Use Committee, and animals were treated humanely and with regard for alleviation of suffering. Briefly, the BALB/c nude mice were kept in a temperature-controlled environment (20-22 C) with a 12 h light dark cycle and with free access to drinking water and chow. For xenograft studies, 1 Â 10 7 MHCC97H cells were injected subcutaneously into the right armpit of the mice (6 mice per group). Three weeks later (after the establishment of the tumors), the As 2 O 3 (0 or 2 mg/ kgÁBW in 100 ll of sterile saline) was administered intraperitoneally (i.p.) every other day. Tumor volumes were measured twice per week by using the formula: V ¼ 1 =2 (width 2 Â length).
After 4 weeks, the mice were sacrificed, and the tumor tissues were removed for further investigation.
Quantitative real-time polymerase chain reaction. Primers used were listed in Supplementary Sphere formation assays. In non-adherent 24-well dishes (Costar), treated MHCC97H cells (2 Â 10 3 ) were suspended in defined, serum-free medium composed of DMEM-F12 (Gibco), 10 ng/ml of human recombinant basic fibroblast growth factor (R&D Systems, Minneapolis), and 10 ng/ml of epidermal growth factor (EGF, R&D Systems). Cells were grown for 10 days and fed every 48 h. Formation of spheres were then counted under a microscope (Olympus, Tokyo, Japan).
Anchorage-independent growth. Soft agar plates were prepared in 24-well dishes with under-layers of 0.70% agarose in DMEM medium supplemented with 10% FBS. To test their capacity for colony growth in soft agar, cells were plated in triplicate at a density of 1 Â 10 3 in 2 ml of 0.35% agarose over the agar base.
Cultures were fed every 3 days; after for 14 days, colonies were counted under a microscope (Olympus).
MicroRNA transfection. Con-mimic, miR-491-mimic, anti-con, and anti-miR-491 were synthesized by RiBoBio Co. Cells were transiently transfected using the Lipofectamine 2000 reagent (Invitrogen), according to the manufacturer's protocol. Briefly, cells were seeded in 6-well plates at a density of 1 Â 10 6 per well.
After 24 h, these cells were transfected with 50 nM anti-miR-491 or 20 nM miR-491-mimic for 12 h. After transfection, cells were cultured in fresh DMEM medium supplemented with 10% FBS (Gibco) for another 24 h before being used for other experiments.
Luciferase reporter assay. The pGL3-SMAD3-3 0 -UTR (wild type or mutant)-Luc constructs were synthesized by Shuntian Biology (Shanghai, China). The plasmid phRL-tk containing the Renilla luciferase gene was purchased from Promega. Briefly, cells were plated in 24-wells cell culture dishes and cultured to 60%-80% confluence; 20 nM of Con-mimic or miR-491-mimc was cotransfected with the reporter constructs, respectively, by using Lipofecamine 2000 reagent (Invitrogen) according to the manufacturer's protocol. After an incubation period of 12 h, the transfection medium was replaced. The cells were lysed with passive lysis buffer (Promega). The cell lysates were analyzed immediately with a 96-well plate luminometer (Berthold Detection System, Pforzheim, Germany). The amounts of luciferase and Renilla luciferase were measured with the DualLuciferase Reporter Assay System Kit (Promega) following the manufacturer's instructions. The values of luciferase activity for each lysate were normalized to the Renilla luciferase activity.
RNA interference. Control-siRNA and SMAD3-siRNA were purchased from Sigma. Transfections were performed with the N-TERTM Nanoparticle siRNA Transfection System (Sigma). Briefly, 1 Â 10 5 MHCC97H or MHCC97L cells were seeded into each well of 6-well plates for 48 h, and then a nanoparticle formation solution containing 20 nM target siRNA was transfected into each well for another 12 h. Then the cells were conventional cultured for 24 h followed by subjected to further experiments.
DNA methylation analysis. Tissue DNA was isolated using DNA purification kits (Qiagen, Germantown, Maryland). The genomic DNA was modified with sodium bisulfite using the EpiTect Kit (Qiagen). DNA methylation was analyzed using a SYBR Greenbased quantitative methylation-specific PCR (qMSP). Primers used were listed in Supplementary Table 2 . Briefly, 1 ll of bisulfite-treated DNA template was mixed with 10 ll of 2Â Power SYBR Green PCR Master Mix (Applied Biosystems) and a pair of primers. The PCR conditions included initial incubation at 50 C for 2 min, denaturing at 95 C for 10 min, and 40 cycles of denaturing at 95 C for 15 s and annealing at 60 C for 1 min.
Immunohistochemistry. Sections mounted on silanized slides were dewaxed in xylene; dehydrated in ethanol; boiled in 0.01 M citrate buffer, pH 6.0, for 20 min in a microwave oven; and then incubated with 3% hydrogen peroxide for 5 min. After washing with PBS, sections were incubated in 10% normal bovine serum albumin for 5 min, followed by overnight incubation with a rabbit antihuman CD133 (Santa Cruz Biotechnology) or SMAD3 (Cell Signaling Technology) antibody, and then with an antirabbit horseradish peroxidase-conjugated secondary antibody (Beyotime) for 30 min. The sections were counterstained with hematoxylin, dehydrated, cleared, and mounted.
Statistical analysis. Data were presented as the means 6 SD. A Student's t test and a one-way analysis of variance followed by Dunnett's t test were used to assess significant differences between groups. P < 0.05 were considered statistically significant.
RESULTS

Effects of As 2 O 3 on the CSCs-Like Properties in HCC Cells
An increased exhibition of CSCs-like properties plays a critical role in the initiation, development, and outcome of HCC (Eaves, 2008) . CD44, CD133, and EpCAM are the cell-surface markers of HCC stem cells, in particular, CD133 is a downstream factor regulated by TGFb (You et al., 2010) . Meanwhile, Oct-4, BMI-1, and Notch are the key "stemness" CSCs-associated factors in various cancers, including HCC (Eaves, 2008) ; of these, Notch is involved in the arsenic-induced attenuation of CSCs-like properties (Wu et al., 2013) . Here in MHCC97L cells, As 2 O 3 significantly decreased the expressions of these genes (Fig. 1A) . Formation of spheroids demonstrates the capacity of cells for self-renewal, which are characteristics of SCs and CSCs (Jiang et al., 2014b) . As shown in Figure 1B , treated MHCC97H cells by As 2 O 3 blocked their ability to form spheroids. Anchorage independent growth is a characteristic of malignant cells (Jiang et al., 2014b) . As well, As 2 O 3 also attenuated the formation of colonies effectively (Fig. 1C) . Collectively, these results suggest that As 2 O 3 decreases the CSCs-like properties in HCC cells.
As 2 O 3 Blocks the Endogenous TGFb Signal by miR-491
Our previous studies reveal that TGFb/SMADs signal is involved in the maintenance of CSCs-like properties in HCC cells, and that As 2 O 3 attenuates the invasion potential in HCC cells by miR-491 (Jiang et al., 2014a; Wang et al., 2014) . Here, interestingly, we found that miR-491 was predicted to bind the SMAD3-3 0 -UTR (the target sites were exhibited in Supplementary Fig.   1A ). As an important transcription factor, SMAD3 plays a key role in the signal transduction initiated by TGFb (Micalizzi et al., 2009 ). So we firstly investigated the effects of miR-491 on the CSCs-like properties in HCC cells. As shown in Supplementary  Figs . 1B-E, over-expression of miR-491 in MHCC97L cells attenuated the expressions of CD44, CD133, and EpCAM mRNAs effectively. Based on these findings, we hypothesized that the repressive effects of As 2 O 3 on the CSCs-like properties might be primarily attributed to miR-491-mediated inhibitions of endogenous TGFb signal. To verify this hypothesis, qRT-PCR and luciferase reporter assay were conducted. In MHCC97L cells, As 2 O 3 elevated the expression of miR-491 ( Fig. 2A) . Moreover, cotransfected with pGL3-SMAD3-3 0 -UTR-Luc construct (WT, but not MT) plus miR-491-mimic led to a significant decrease of the luciferase activity (Fig. 2B) . Further, we investigated the functional relevance between the miR-491's binding effects and the expression/function of SMAD3. As shown in Figures 2C and 2D , overexpression of miR-491 attenuated the expressions of SMAD3 mRNA, protein, and its target gene, snail . Next, we determined whether As 2 O 3 could block the endogenous TGFb signaling by miR-491. In MHCC97H cells, the expression miR-491 was blocked by its specific inhibitor (antimiR-491). As shown in Figures 2E and 2F Figure 3A , knockdown of miR-491 blocked the As 2 O 3 -induced decreased expressions of CD44, CD133, and EpCAM. In addition, (mean 6 SD, n ¼ 3). B, MHCC97L cells were co-transfected with the reporter constructs plus 20 nM con-mimic or miR-491-mimc for 12 h, respectively. Luciferase reporter assay analyses in triplicate of the effects of miR-491 on SMAD3 3 0 -UTR (mean 6 SD, n ¼ 3). C and D, MHCC97L cells were transfected by 20 nM con-mimic or miR-491-mimic for 12 h, (C) qRT-PCR analyses in triplicate of the SMAD3 and snail mRNA (mean 6 SD, n ¼ 3), (D) Western blots analyses of SMAD3. E and F, After MHCC97H cells were pretransfected by anti-con or anti-miR-491 for 12 h, they were exposed to 10 lM As2O3 for 72 h. E, qRT-PCR analyses in triplicate of the miR-491, SMAD3, and snail mRNA (mean 6 SD, n ¼ 3). F, Western blots analyses of p-SMAD3, SMAD3, and snail protein. **P < 0.01 compared with medium control cells or with cells transfected by con-mimic; ## P < 0.01 compared with cells transfected by anti-con.
knockdown of miR-491 also attenuated the As 2 O 3 -induced decreased formation of spheroids ( Fig. 3B ) and anchorage-independent growth (Fig. 3C) . Next, to further confirm more directly that the SMAD3 was involved in the inhibition of CSCs-like properties by As 2 O 3 , we knocked down SMAD3 using its specific siRNA as exhibited in Figure 4A . Interestingly, in SMAD3 knockdown MHCC97H cells, the background expressions of CD44, CD133, and EpCAM were significantly decreased compared with con-siRNA-transfected cells. Furthermore, the inhibition extent, that the As 2 O 3 -induced attenuated expressions of these 3 mRNAs, was also markedly decreased in SMAD3-knockdown cells (Figs. 4B-D) . Importantly, specific knockdown of SMAD3 had no detectable effect on As 2 O 3 -induced miR-491 expression compared with con-siRNA-transfected cells (Fig. 4A) . Collectively, these results indicate that miR-491/SMAD3 signal pathway contributes to the As 2 O 3 's ability to inhibit the CSCslike properties in vitro.
Effects of As 2 O 3 on miR-491/SMAD3 and CSCs-Like Properties In Vivo Then, we investigated the effects of As 2 O 3 on miR-491/SMAD3 signaling and on the CSCs-like properties of HCC cells in vivo. As shown in Figure 5A , As 2 O 3 decreased the tumor growth effectively. Next, we further determined the effects of As 2 O 3 on the expressions of miR-491, SMAD3, and CSCs-like markers. Notably, by using immunohistochemistry and qRT-PCR, we found that, in As 2 O 3 -treated group, there were decreased expressions of SMAD3 and Nanog (a CSCs self-renewal inducer, which regulates the EMT process via SMAD3 in HCC [Shan et al., 2012; Sun et al., 2013] ), but increased expression of miR-491 (Figs. 5B and 5C). In addition, As 2 O 3 also attenuated the expressions of "stemness" CSCs-associated factors, CD133 and Notch (Fig. 5C ). Our previous study demonstrates that As 2 O 3 improves the expression of miR-491 by DNA-demethylation in vitro . Here, by using qMSP, we also confirmed that As 2 O 3 decreased the average methylation level of miR-491 promoter in vivo (Fig. 5D) . Collectively, these results suggest that by abolishing the epigenetic silence of miR-491, As 2 O 3 blocks the endogenous TGFb/SMAD3 signal, which attenuates the CSCslike properties of HCC in vivo.
Correlations Between miR-491 and Survival in HCC Patients
We previously show that the upregulation of miR-491 is positive correlated with the well-differentiated status of HCC . Here, based on our findings that miR-491 targets SMAD3, which in turn attenuates the CSCs-like properties in HCC, and on the fact that CSCs play a key role in cancer recurrence (Eaves, 2008) . We hypothesized that there were correlations between miR-491 and survival in HCC. Firstly, we investigated the expression of miR-491 in HCC tissues samples (n ¼ 60), and divided the HCC tissue samples into two groups (miR-491 high and miR-491 low), the high and low expressions were defined according to the cut-off values for miR-491, which were defined as the median of the cohort (Supplementary Fig.  2) . Notably, by using immunohistochemistry and qRT-PCR, we found that the expressions of SMAD3 and Nanog in miR-491 high group were significantly lower than those in miR-491 low group (Figs. 6A and 6B). Next, we further determined the relationship between miR-491 and survival of HCC patients. As shown in Figure 6C , Kaplan-Meier survival curves of patients with HCC indicated that the 2-year overall survival rate of HCC patients with low miR-491 expressions was significantly lower than that of HCC patients with high miR-491 expressions. These results suggest that by the attenuations of SMAD3 and CSCs-like properties, miR-491 is positively correlated with the survival of HCC.
DISCUSSION
Inorganic arsenic functions as a double-edged sword to the human health. Although epidemiologic evidence implicates exposure to arsenic in causing human cancers of the skin, lung, and bladder, arsenic has also been used clinically as an antitumor agent in leukemia as well as other solid tumors (Huang et al., 2004; Wu et al., 2013) . In the molecular mechanisms, activation of caspase cascade, decrease of mitochondrial membrane potential, production of reactive oxygen species, induction of G1 and/or G2 phase arrest are involved (Chow et al., 2004; Fei et al., 2009) . Additionally, current studies revealed that As 2 O 3 attenuates the metastasis by inhibiting nuclear factor jB (NF-jB), and by activating miRNAs, such as miR-200 c and miR-491 Wang et al., 2014) . For the relationship between arsenic and CSCs-like properties, previous study showed that As 2 O 3 decreases the CSCs population and/or induces the CSCs differentiation in pancreatic cancer, gliomas, glioblastoma, and HCC, in the molecular mechanisms, the blockage of signal transduction induced by Notch or GLI1 are involved Wu et al., 2013; Zhang et al., 2014; Zhen et al., 2010) . In addition, As 2 O 3 modifies the expressions of a serial of miRNAs, such as miR-98, miR-30, miR-210, and miR-200 c, which are involved in the regulation of differentiation and self-renewal (Gao et al., 2014; Meng et al., 2011; Si et al., 2014; Yang et al., 2014) . Here in our present study, exposure of HCC cells to As 2 O 3 decreased the CSCs-like properties effectively in vitro and in vivo. Further, we revealed a novel mechanism underlying in such process, which was the inhibition of endogenous TGFb/SMAD3 signaling. In general, TGFb signaling is initiated upon binding of TGFb to the membrane receptors, TGFb receptors type I (TbRI) and TbRII, which in turn, induces the phosphorylation of its cytoplasmic effectors, SMAD2 and SMAD3. Then the phosphorylated SMAD2/3 binds to their mediator protein, SMAD4, and translocate to the nucleus, leaded to the transcriptional regulation of its target genes (Jiang et al., 2014a) . It has been well established that, TGFb has conflicting effects during tumor progression, initially as a suppressor and then as a promoter. The current paradigm is that high TGFb1, indicating the lack of TGFb1 inhibition because of loss of receptors, is associated with increased risk of disease progression and death among patients with early-stage disease, however, it is associated with decreased risk among patients with late-stage disease (Mu et al., 2008) . Although the switch of TGFb from a tumor suppressor to a tumor promoter is not well defined, to date, more evidences suggest that TGFb plays important roles as the activator, which promotes tumor growth, metastasis, and angiogenesis (Majumdar et al., 2012) .
Recently, the TGFb inhibitors are being developed as antimetastatic therapy for patients with cancer (Bueno et al., 2008; Micalizzi et al., 2009) . For the treatment of CSCs, knockdown or pharmacological inhibition of the ALK4/7 (the TGFb type I receptor activin receptor-like kinase) in pancreatic CSCs potently abrogates their self-renewal capacity, suppresses the growth of primary human pancreatic cancer xenografts, and reversed the resistance of orthotopically engrafted CSCs to the standard chemotherapeutic, gemcitabine (Lonardo et al., 2011) . In triplenegative breast cancer (TNBC) cell lines and mouse xenografts, the chemotherapeutic drug, paclitaxel, increases the autocrine TGFb, which causes the elevation of breast CSCs, as indicated by mammosphere formation and CSCs markers. Importantly, inhibition of TGFb signaling by LY2157299, a neutralizing TGFb type II receptor antibody, or by SMAD4 siRNA all blocked paclitaxel-induced breast CSCs expansion, suggesting that inhibition of TGFb blocks the generation of CSCs, which enhances chemotherapeutic action against TNBC (Bhola et al., 2013) . Meanwhile, previous study suggests that the TGFb is required for nuclear factor kappa B (NF-jB)-dependent gene expression (Hogan et al., 2013) . It has been well established that the NF-jB-mediated autocrine IL-6 signaling has been identified as a key regulator in the malignant progression of HCC (He et al., 2013) . So the suppression of TGFb signal may become an important strategy for HCC treatment. Here, we identified that binding of miR-491 to the 3 0 -UTR region of SMAD3 mRNA facilitates the As 2 O 3 -induced inhibition of endogenous TGFb signaling. MicroRNAs are small non-coding RNAs that regulate gene expression by binding to the 3 0 -UTR of the target mRNA and inhibiting translation or targeting the mRNA for degradation . Abnormal expressions of miRNAs are associated with a variety of human cancers, including HCC Zhou et al., 2013) . MiR-491 has been identified as an important tumor suppressor in a lot of human cancers. It was first shown to induce the apoptosis by targeting Bcl-XL in colorectal cancer cells (Nakano et al., 2010) . Moreover, it also targets both TP53 and Bcl-XL induced cell apoptosis in pancreatic cancer cells through mitochondria-mediated pathway (Guo et al., 2012) . In addition, miR-491 has been recognized as an antimetastasis gene by targeting MMP9 and G-protein-coupled receptor kinase-interacting protein 1 (Huang et al., 2014; Zhou et al., 2013) . Further, miR-491 attenuates the malignant properties by targeting a serial of oncogenes, such as EGFR, Wnt signal, and GIT-1 (Hrdlickova et al., 2014; Huang et al., 2014; Li et al., 2014) . These genes probably elevate the CSCs-like properties in cancer cells (Arasada et al., 2014; Wang et al., 2014; Yan et al., 2013) . So, the molecular mechanisms underlying in the repressive effects on CSCs-like properties induced by As 2 O 3 or miR-491 are very complicated. Our present study indicates one of the potential mechanisms that the miR-491-mediated inhibition of SMAD3 was involved in the As2O3-induced attenuation of CSCs-like properties in HCC cells. By revealing a novel mechanism whereby As 2 O 3 inhibits the CSCs-like properties, our present study expands the understanding of the therapy potential of arsenic trioxide in HCC. 
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